Litcius/Paper detail

The efficacy and safety of systemic corticosteroids as first line treatment for granulomatous lymphocytic interstitial lung disease

Bas M. Smits, Sigune Goldacker, Suranjith L. Seneviratne, Marion Malphettes, Hilary Longhurst, Omar E. Mohamed, Carla Witt-Rautenberg, Lucy Leeman, Eva C. Schwaneck, Isabelle Raymond‐Letron, Kilifa Meghit, Annette Uhlmann, Christine Winterhalter, Joris M. van Montfrans, Marion Klima, Sarita Workman, Claire Fieschi, Lorena Lorenzo, Sonja Boyle, Shamin Onyango-Odera, Suzanne Price, Marc Schmalzing, Valerie Aurillac, Antje Prasse, Ieneke J. C. Hartmann, Jennifer J. Meerburg, Mariette Kemner-van de Corput, Harm A.W.M. Tiddens, Bodo Grimbacher, Peter Kelleher, Smita Y. Patel, Anne‐Sophie Korganow, Jean‐François Viallard, Hans‐Peter Tony, Claire Bethune, Hendrik Schulze‐Koops, Torsten Witte, Aarnoud Huissoon, Helen Baxendale, Sofia Grigoriadou, Éric Oksenhendler, Siobhan O. Burns, Klaus Warnatz

2022Journal of Allergy and Clinical Immunology25 citationsDOIOpen Access PDF

Topics & Concepts

MedicineInterstitial lung diseasePrednisoneHigh-resolution computed tomographyCorticosteroidPulmonary function testingInternal medicineDiffusing capacityGastroenterologyLungDLCORetrospective cohort studySurgeryLung functionInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisInflammatory Myopathies and DermatomyositisSarcoidosis and Beryllium Toxicity Research
The efficacy and safety of systemic corticosteroids as first line treatment for granulomatous lymphocytic interstitial lung disease | Litcius